Prognostic value of infection and inflammation markers for late cardiac events in an Iranian sample

Eastern Mediterranean Health Journal

Volumn 14, Issue 6, 2008, Pages 1246-1256

  Sarrafzadegan, Nizal ^a   Rezaporian, P ^a   Kaypour, M ^a   Mohseni, M ^a   Sadeghi, M ^a   Asgary, S ^a   Sabet, B ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN G ANTIBODY; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDIASIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; FEMALE; HEART DEATH; HELICOBACTER INFECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; SMOKING; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; CHLAMYDOPHILA INFECTION; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; HEART MUSCLE ISCHEMIA; HELICOBACTER PYLORI; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; STATISTICAL MODEL;

ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FIBRINOGEN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 59949098420     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Becker RC et al. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial). American journal of cardiology, 1996, 78:142-7.
2. ECAT Angina Pectoris Study Group. ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. European heart journal, 1993, 14:8-17.
3. Liuzzo G et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New England journal of medicine, 1994, 331:417-24.
4. Liuzzo G et al. Plasma protein acute phase response in unstable angina is not induced by ischemic injury. Circulation, 1996, 94:2374-80.
5. Adiloglu AK et al. Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels. Acta cardiologica, 2005, 60:599-604.
6. Fraser AG et al. Helicobacter pylori, Chlamydia pneumoniae and myocardial infection. Internal medicine journal, 2003, 33:267-72.
7. Kinjo K et al. Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circulation journal, 2002, 66:805-10.
8. Gabrylewicz B et al. Cytomegalovirus infection in acute myocardial infarction. Is there a causative relationship? Kardiologia polska, 2003, 69:283-92.
9. Zhu J et al. Lack of association of Helicobacter pylori infection and frequency of acute myocardial infarction or death. American journal of cardiology, 2002, 15:155-8.
10. Zibaeenezhad MJ et al. Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran. Angiology, 2005, 56(1):43-8.
11. Bermejo Garcia J et al. Inflamacion e infeccion en la enfermedad coronaria estable y en el sindrome coronario agudo [Inflammation and infection in stable coronary disease and acute coronary syndrome]. Revista española de cardiología, 2001, 54:453-9.
12. Sarraf-Zadegan N et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta cardiologica, 1999, 54:257-63.
13. Sarraf-Zadegan N, Boshtam M, Rafiei M. Risk factors for coronary artery disease in Isfahan, Iran. European journal of public health, 1999, 9(1):20-5.
14. Rose G, Blackburn H, Gillum R, eds. Cardiovascular survey methods, 2nd ed. Geneva, World Health Organization, 1982.
15. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. [Rapid physiological coagulation method in determination of fibrinogen]. Acta haematologica, 1957, 17:237-46.
16. Bogaty P et al. Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation, 1993, 87:1938-46.
17. Cianflone D et al. Comparison of coronary angiographic narrowing in stable angina pectoris, unstable angina pectoris, and in acute myocardial infarction. American journal of cardiology, 1995, 76:215-9.
18. Arbustini E et al. Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. American journal of cardiology, 1995, 75:675-82.
19. Van der Wal AC et al. Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques. Heart, 1996, 76:312-6.
20. Belomo G et al. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study. Journal of nephrology, 2003, 16:245-51.
21. Liuzzo G et al. Helicobacter pylori and Cytomegalovirus infections are strongly associated with atherosclerosis but not responsible for instability of angina. Journal of the American College of Cardiology, 1997, 29(Suppl. A):217A.
22. Biasucci LM et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation, 1999, 99:855-60.
23. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 2001, 103(13):1813-8.
24. Krobot K et al. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arteriosclerosis and thrombosis, 1992, 12:780-8.
25. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes care, 1999, 22:1971-7.
26. Liu Y et al. Evidence for activation of endothelium and monocytes in hypertensive rats. American journal of physiology, 1996, 270(6Pt. 2):H2125-31.
27. Eriksson M et al. Relationship between plasma fibrinogen and coronary heart disease in women. Arteriosclerosis, thrombosis, and vascular biology, 1999, 19:67-72.
28. Patel P et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. British medical journal, 1995, 311:711-14.
29. Sarraf-Zadegan N, Amiri M, Maghsoudloo S. Helicobacter pylori relation to acute myocardial infarction in an Iranian sample. Coronary health care, 2001, 5:202-7.
30. Eryol NK et al. Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease? International heart journal, 2005, 46:205-9.
31. Prosch S et al. A novel link between stress and human cytomegalovirus (HCMV) hyperactivity infection: sympathetic hyperactivity stimulates HCMV activation. Virology, 2000, 5:357-65.
32. Jantos CA et al. Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease. Clinical infectious diseases, 1999, 28:988-92.
33. Hoymans VY et al. Immunohistostaining assays for detection of Chlamydia pneumonia in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents. Journal of clinical microbiology, 2004, 42:3219-24.
34. Mahara B et al. Is there perceived association between Chlamydia pneumoniae and vascular disease biased by methodology? Journal of clinical microbiology, 2004, 42:3937-41.
35. Meijer A et al. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions. Journal of clinical pathology, 2000, 53:911-6.
36. Gaydos CA et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection Chlamydia pneumoniae in symptomatic and asymptomatic patients. Journal of clinical microbiology, 1994, 32:903-5.
37. Danesh J, Whincup P, Walker M. Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. European heart journal, 2003, 24:881.
38. Romano S et al. Chlamydia pneumoniae infection in patients with acute coronary syndrome: a clinical and serological 1-year follow-up. International journal of immunopathology and pharmacology, 2004, 17:209-18.
39. Hoymans VY et al. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis Journal of clinical microbiology, 2003, 41:4049-53.
40. Maraha B et al. Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases. Clinical and diagnostic laboratory immunology, 2004, 11:789-91.
41. Gupta S et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation, 1997, 96:404-7.
42. Gurfinkel E et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet, 1997, 350:404-7.
43. Grayston JT et al. Azithromycin for the secondary prevention of coronary events. New England journal of medicine, 2005, 352:1637-45.
44. Cannon CP et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. New England journal of medicine, 2005, 352:1646-54.
45. Muhlestein JB et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation, 2000, 102:1755-60.
46. Higgins JP. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials. Mayo Clinic proceedings, 2003, 78:321-32.
47. Taylor-Robinson D, Boman J. The failure of antibiotics to prevent heart attacks. British medical journal, 2005, 331:361-2.